Barinthus Biotherapeutics (BRNS) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free BRNS Stock Alerts $1.91 -0.09 (-4.50%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Barinthus Biotherapeutics Stock Price Performance5 Day Performance-13.57%1 Month Performance-13.18%3 Month Performance-35.25%6 Month Performance-39.37%Year-To-Date Performance-48.24% Receive BRNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. BRNS Stock Chart for Saturday, June, 1, 2024 BRNS Chart by TradingView Barinthus Biotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.00$1.91-4.50%$2.05$1.8635,080 shs$78.07 million05/30/2024$2.09$2.00-4.31%$2.14$1.9919,561 shs$78.06 million05/29/2024$2.26$2.09-7.52%$2.26$2.0039,969 shs$81.57 million05/28/2024$2.21$2.26+2.26%$2.34$2.097,430 shs$88.21 million05/27/2024$2.21$2.21$2.26$2.0719,300 shs$86.26 million05/24/2024$2.35$2.21-5.96%$2.26$2.0719,385 shs$86.26 million Get the Latest News and Ratings for BRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.30$2.35+2.17%$2.35$2.243,643 shs$91.72 million05/22/2024$2.32$2.30-0.86%$2.35$2.2010,818 shs$89.77 million05/21/2024$2.40$2.32-3.33%$2.39$2.153,600 shs$90.56 million05/20/2024$2.35$2.40+2.13%$2.44$2.401,410 shs$93.67 million05/17/2024$2.43$2.35-3.29%$2.35$2.35375 shs$91.46 million05/16/2024$2.22$2.43+9.45%$2.43$2.275,789 shs$94.57 million05/15/2024$2.32$2.22-4.31%$2.33$2.209,472 shs$86.40 million05/14/2024$2.35$2.32-1.07%$2.35$2.266,543 shs$90.29 million05/13/2024$2.34$2.35+0.43%$2.42$2.217,495 shs$91.27 million05/10/2024$2.35$2.29-2.55%$2.45$2.278,563 shs$89.13 million05/09/2024$2.27$2.35+3.52%$2.40$2.2310,227 shs$91.46 million05/08/2024$2.27$2.27$2.45$2.214,606 shs$88.35 million05/07/2024$2.21$2.27+2.71%$2.40$2.222,347 shs$88.35 million05/06/2024$2.18$2.21+1.38%$2.25$2.167,930 shs$86.02 million05/03/2024$2.20$2.18-0.91%$2.28$2.145,110 shs$84.85 million05/02/2024$2.20$2.20$2.29$2.153,060 shs$85.62 million05/01/2024$2.05$2.20+7.32%$2.25$2.0317,671 shs$85.63 million04/30/2024$2.59$2.05-20.85%$2.59$1.82175,738 shs$79.79 million04/29/2024$2.50$2.59+3.60%$2.59$2.364,158 shs$100.80 million04/26/2024$2.43$2.50+2.88%$2.60$2.406,864 shs$97.30 million04/25/2024$2.51$2.43-3.19%$2.54$2.402,824 shs$94.58 million04/24/2024$2.60$2.51-3.46%$2.61$2.505,008 shs$97.69 million04/23/2024$2.62$2.60-0.76%$2.63$2.507,993 shs$101.19 million04/22/2024$2.51$2.62+4.38%$2.66$2.5020,222 shs$101.97 million04/19/2024$2.67$2.53-5.43%$2.72$2.513,440 shs$98.27 million04/18/2024$2.60$2.67+2.69%$2.77$2.538,039 shs$103.92 million04/17/2024$2.53$2.60+2.77%$2.67$2.596,497 shs$101.19 million04/16/2024$2.64$2.53-4.24%$2.77$2.5118,051 shs$98.47 million04/15/2024$3.14$2.64-15.86%$2.97$2.6035,545 shs$102.83 million04/12/2024$3.33$3.14-5.71%$3.21$2.962,700 shs$122.21 million04/11/2024$3.23$3.33+3.10%$3.51$3.1013,170 shs$129.60 million04/10/2024$3.29$3.23-1.82%$3.40$3.1014,492 shs$125.71 million04/09/2024$3.24$3.29+1.54%$3.47$3.183,968 shs$128.05 million04/08/2024$3.30$3.24-1.82%$3.64$3.1818,097 shs$126.10 millionBiden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here.04/05/2024$3.67$3.30-10.08%$3.67$3.3050,689 shs$128.44 million04/04/2024$2.91$3.67+26.12%$4.16$2.84164,432 shs$142.84 million04/03/2024$2.37$2.91+22.78%$3.05$2.37218,182 shs$113.26 million04/02/2024$2.45$2.37-3.27%$2.48$2.373,479 shs$91.39 million04/01/2024$2.38$2.45+2.94%$2.46$2.3820,588 shs$94.47 million03/29/2024$2.38$2.38$2.47$2.3132,846 shs$91.77 million03/28/2024$2.33$2.38+2.15%$2.47$2.3132,846 shs$91.79 million03/27/2024$2.40$2.33-2.92%$2.40$2.3130,875 shs$89.85 million03/26/2024$2.41$2.40-0.41%$2.40$2.2532,388 shs$92.54 million03/25/2024$2.58$2.41-6.59%$2.46$2.267,961 shs$92.93 million03/22/2024$2.41$2.58+7.05%$2.60$2.3233,023 shs$99.48 million03/21/2024$2.35$2.41+2.55%$2.45$2.277,428 shs$92.93 million03/20/2024$2.41$2.35-2.49%$2.57$2.1710,496 shs$90.62 million03/19/2024$2.43$2.41-0.82%$2.52$2.3817,942 shs$92.93 million03/18/2024$2.47$2.43-1.80%$2.47$2.2713,914 shs$93.70 million03/15/2024$2.51$2.47-1.59%$2.49$2.4312,157 shs$95.24 million03/14/2024$2.55$2.51-1.56%$2.53$2.437,378 shs$96.80 million03/13/2024$2.58$2.55-1.17%$2.61$2.464,542 shs$98.32 million03/12/2024$2.66$2.58-3.01%$2.59$2.457,075 shs$99.49 million03/11/2024$2.60$2.66+2.31%$2.66$2.4789,961 shs$102.57 million03/08/2024$2.65$2.60-1.89%$2.75$2.555,275 shs$100.26 million03/07/2024$2.70$2.65-1.85%$2.80$2.532,504 shs$102.18 million03/06/2024$3.06$2.70-11.76%$2.95$2.5029,297 shs$104.11 million03/05/2024$2.95$3.06+3.73%$3.20$2.7315,143 shs$117.99 million03/04/2024$2.95$2.95$3.10$2.8724,599 shs$113.77 million03/01/2024$2.83$2.95+4.24%$3.05$2.8616,439 shs$113.75 million02/29/2024$2.82$2.83+0.35%$3.00$2.8311,865 shs$109.14 million Related Companies: KMDA Stock Chart AVIR Stock Chart RVNC Stock Chart EPIX Stock Chart XOMA Stock Chart MRSN Stock Chart VNDA Stock Chart CRMD Stock Chart INZY Stock Chart ANL Stock Chart Receive BRNS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BRNS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.